Three-Year Outcomes After Sirolimus-Eluting Stent Implantation for Unprotected Left Main Coronary Artery Disease Insights From the j-Cypher Registry

被引:78
|
作者
Toyofuku, Mamoru [4 ]
Kimura, Takeshi [1 ]
Morimoto, Takeshi [2 ,3 ]
Hayashi, Yasuhiko [4 ]
Ueda, Hiroaki [4 ]
Kawai, Kazuya [8 ]
Nozaki, Yoichi [7 ]
Hiramatsu, Shinichi [6 ]
Miura, Akira [5 ]
Yokoi, Yoshiaki [13 ]
Toyoshima, Shinichiro [12 ]
Nakashima, Hitoshi [11 ]
Haze, Kazuo [10 ]
Tanaka, Masaru [9 ]
Take, Shunsuke [16 ]
Saito, Shigeru [15 ]
Isshiki, Takaaki [14 ]
Mitsudo, Kazuaki [17 ]
机构
[1] Kyoto Univ, Grad Sch Med, Dept Cardiovasc Med, Sakyo Ku, Kyoto 6068507, Japan
[2] Kyoto Univ, Grad Sch Med, Ctr Med Educ, Kyoto 6068507, Japan
[3] Kyoto Univ, Grad Sch Med, Clin Epidemiol Unit, Kyoto 6068507, Japan
[4] Tsuchiya Gen Hosp, Hiroshima, Japan
[5] Japanese Red Cross Soc Wakayama Med Ctr, Wakayama, Japan
[6] Ehime Prefectural Cent Hosp, Matsuyama, Ehime, Japan
[7] Hokko Mem Hosp, Sapporo, Hokkaido, Japan
[8] Chikamori Hosp, Kochi, Japan
[9] Osaka Red Cross Hosp, Osaka, Japan
[10] Osaka City Gen Hosp, Osaka, Japan
[11] Natl Hosp Org Kagoshima Med Ctr, Kagoshima, Japan
[12] Nanpuh Hosp, Kagoshima, Japan
[13] Kishiwada Tokushukai Hosp, Kishiwada, Japan
[14] Teikyo Univ Hosp, Tokyo, Japan
[15] Shonan Kamakura Gen Hosp, Kamakura, Kanagawa, Japan
[16] Saiseikai Noe Hosp, Osaka, Japan
[17] Kurashiki Cent Hosp, Kurashiki, Okayama, Japan
关键词
stents; revascularization; coronary disease; ischemia; restenosis; BYPASS-SURGERY; THROMBOSIS; STENOSIS; SURVIVAL;
D O I
10.1161/CIRCULATIONAHA.109.873349
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background-Long-term outcomes after stenting of an unprotected left main coronary artery (ULMCA) with drug-eluting stents have not been addressed adequately despite the growing popularity of this procedure. Methods and Results-j-Cypher is a multicenter prospective registry of consecutive patients undergoing sirolimus-eluting stent implantation in Japan. Among 12 824 patients enrolled in the j-Cypher registry, the unadjusted mortality rate at 3 years was significantly higher in patients with ULMCA stenting (n = 582) than in patients without ULMCA stenting (n = 12 242; 14.6% versus 9.2%, respectively; P < 0.0001); however, there was no significant difference between the 2 groups in the adjusted risk of death (hazard ratio 1.23, 95% confidence interval 0.95 to 1.60, P = 0.12). Among 476 patients whose ULMCA lesions were treated exclusively with a sirolimus-eluting stent, patients with ostial/shaft lesions (n = 96) compared with those with bifurcation lesions (n = 380) had a significantly lower rate of target-lesion revascularization for the ULMCA lesions (3.6% versus 17.1%, P = 0.005), with similar cardiac death rates at 3 years (9.8% versus 7.6%, P = 0.41). Among patients with bifurcation lesions, patients with stenting of both the main and side branches (n = 119) had significantly higher rates of cardiac death (12.2% versus 5.5%; P = 0.02) and target-lesion revascularization (30.9% versus 11.1%; P < 0.0001) than those with main-branch stenting alone (n = 261). Conclusions-The higher unadjusted mortality rate of patients undergoing ULMCA stenting with a sirolimus-eluting stent did not appear to be related to ULMCA treatment itself but rather to the patients' high-risk profile. Although long-term outcomes in patients with ostial/shaft ULMCA lesions were favorable, outcomes in patients with bifurcation lesions treated with stenting of both the main and side branches appeared unacceptable. (Circulation. 2009;120:1866-1874.)
引用
收藏
页码:1866 / U50
页数:16
相关论文
共 50 条
  • [21] Three-Year Outcomes Following Sirolimus- Versus Paclitaxel-Eluting Stent Implantation in an Unselected Population With Coronary Artery Disease (from the REWARDS Registry)
    Hanna, Nicholas N.
    Gaglia, Michael A., Jr.
    Torguson, Rebecca
    Ben-Dor, Itsik
    Gonzalez, Manuel A.
    Collins, Sara D.
    Syed, Asmir I.
    Maluenda, Gabriel
    Kaneshige, Kimberly
    Xue, Zhenyi
    Satler, Lowell F.
    Kent, Kenneth M.
    Suddath, William O.
    Pichard, Augusto D.
    Waksman, Ron
    AMERICAN JOURNAL OF CARDIOLOGY, 2010, 106 (04) : 504 - 510
  • [22] Fifteen-Year Clinical Outcomes After Sirolimus-Eluting Stent Implantation
    Nishiura, Naoki
    Kubo, Shunsuke
    Fujii, Chihiro
    Shima, Yuki
    Ikuta, Akihiro
    Osakada, Kohei
    Tada, Takeshi
    Fuku, Yasushi
    Tanaka, Hiroyuki
    Kadota, Kazushige
    CIRCULATION JOURNAL, 2024, 88 (06) : 938 - 943
  • [23] Sirolimus-eluting stent implantation for ostial stenosis of left main coronary artery after Bentall operation in aortitis syndrome
    Terasawa, Akihiro
    Kondo, Keita
    Ishikawa, Shinji
    Morimoto, Ryota
    Tajika, Toru
    Hayashi, Yuzo
    JOURNAL OF CARDIOLOGY, 2010, 55 (01) : 147 - 150
  • [24] Sirolimus-versus paclitaxel-eluting stent implantation for unprotected left main coronary artery stenosis
    Lee, SH
    Ko, YG
    Jang, J
    Kwon, HM
    Lee, SH
    Yoon, JH
    Park, SH
    Kim, BO
    Jeon, DW
    Yang, JY
    Ryu, SK
    CARDIOLOGY, 2005, 104 (04) : 181 - 185
  • [25] Three-year clinical outcomes of a sirolimus-eluting bioresorbable scaffold (XINSORB) and a metallic stent to treat coronary artery stenosis
    Wu, Yizhe
    Yao, Zhifeng
    Yin, Jiasheng
    Chen, Jiahui
    Qian, Juying
    Shen, Li
    Ge, Lei
    Ge, Junbo
    ANNALS OF TRANSLATIONAL MEDICINE, 2020, 8 (22)
  • [26] Significant Association of Coronary Artery Calcification in Stent Delivery Route With Restenosis After Sirolimus-Eluting Stent Implantation
    Mori, Shumpei
    Yasuda, Satoshi
    Kataoka, Yu
    Morii, Isao
    Kawamura, Atsushi
    Miyazaki, Shunichi
    CIRCULATION JOURNAL, 2009, 73 (10) : 1856 - 1863
  • [27] Five-Year Follow-Up After Sirolimus-Eluting Stent Implantation Results of the SIRIUS (Sirolimus-Eluting Stent in De-Novo Native Coronary Lesions) Trial
    Weisz, Giora
    Leon, Martin B.
    Holmes, David R., Jr.
    Kereiakes, Dean J.
    Popma, Jeffrey J.
    Teirstein, Paul S.
    Cohen, Sidney A.
    Wang, Hong
    Cutlip, Donald E.
    Moses, Jeffrey W.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2009, 53 (17) : 2009 - 1497
  • [28] Stent Fracture After Sirolimus-Eluting Stent Implantation 8-Year Clinical Outcomes
    Ohya, Masanobu
    Kadota, Kazushige
    Tada, Takeshi
    Habara, Seiji
    Shimada, Takenobu
    Amano, Hidewo
    Izawa, Yu
    Hyodo, Yusuke
    Miyake, Koshi
    Otsuru, Suguru
    Hasegawa, Daiji
    Tanaka, Hiroyuki
    Maruo, Takeshi
    Katoh, Harumi
    Fuku, Yasushi
    Goto, Tsuyoshi
    Mitsudo, Kazuaki
    CIRCULATION-CARDIOVASCULAR INTERVENTIONS, 2015, 8 (08)
  • [29] Sirolimus-eluting stent for in-stent restenosis of left main coronary artery in Takayasu arteritis
    Furukawa, Y
    Tamura, T
    Toma, M
    Abe, M
    Saito, N
    Ehara, N
    Taniguchi, R
    Nakagawa, Y
    Kita, T
    Kimura, T
    CIRCULATION JOURNAL, 2005, 69 (06) : 752 - 755
  • [30] Randomized Comparison of Percutaneous Coronary Intervention With Sirolimus-Eluting Stents Versus Coronary Artery Bypass Grafting in Unprotected Left Main Stem Stenosis
    Boudriot, Enno
    Thiele, Holger
    Walther, Thomas
    Liebetrau, Christoph
    Boeckstegers, Peter
    Pohl, Tilmann
    Reichart, Bruno
    Mudra, Harald
    Beier, Florian
    Gansera, Brigitte
    Neumann, Franz-Josef
    Gick, Michael
    Zietak, Thomas
    Desch, Steffen
    Schuler, Gerhard
    Mohr, Friedrich-Wilhelm
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2011, 57 (05) : 538 - 545